Denali Therapeutics (DNLI) Prices 13.89M Share IPO at $18/Sh

Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its initial public offering of 13,888,888 shares of its common stock at a price to the public of $18.00 per share. In addition, the underwriters have a 30-day option to purchase up to 2,083,333 additional shares of common stock at the initial public offering price less underwriting discounts and commissions. The shares are expected to begin trading on the NASDAQ Global Select Market on December 8, 2017 under the symbol “DNLI.” The offering is expected to close on December 12, 2017, subject to customary closing conditions.

Goldman Sachs & Co. LLC, Morgan Stanley and J.P. Morgan are acting as joint book-running managers for the offering, and Evercore Group L.L.C. is acting as lead manager for the offering.

You May Also Be Interested In

• Marex Group (MRX) Prices 15.38M Share IPO at $19/sh
• YY Group Holding (YYGH) Closes $5M IPO
• Neo-Concept International Group Holdings (NCI) Prices 2.32M Share IPO at $4/sh